Evaluation of safety outcomes with transitioning obinutuzumab from standard rate to short duration infusion in patients with chronic lymphocytic leukemia.
作者信息
Fleck Caroline, Karabinos Allison, Cook Allene, Moore Donald C, Jacobs Ryan
机构信息
Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
出版信息
Leuk Lymphoma. 2024 Aug;65(8):1198-1199. doi: 10.1080/10428194.2024.2341999. Epub 2024 Apr 22.
Abstract
摘要
Zotero 插件